filmov
tv
Management of Low-Risk Polycythemia Vera
Показать описание
Treatment options and supportive care strategies that can be used to best manage patients with low-risk polycythemia vera
Management of Low-Risk Polycythemia Vera
The role of interferon in polycythemia vera & perspectives on the management of low-risk patient...
Use of Cytoreductive Therapy in Patients with Low Risk Polycythemia Vera
New guidelines for the treatment and management of polycythemia vera
LOW-PV interim analysis: Ropeginterferon versus phlebotomy in low-risk polycythemia vera
The treatment of low and high-risk polycythemia vera
The management of polycythemia vera with cytoreductive drug therapy
How does assessing risk in polycythemia vera (PV) help you design treatment plans?
Prognostication and initiation of therapy in Polycythemia vera: Do we have it right?
Treatment goals in Essential Thrombocythemia and Polycythemia vera
The need to improve diagnostic criteria in PV and other challenges in the field
Ropeginterferon vs standard therapy for polycythemia vera
Management of Low-Risk Primary Myelofibrosis
Ropeginterferon Alfa-2b for the treatment of low-risk patients with polycythemia vera
Should ropeginterferon become SoC for all patients with low-risk PV?
My view on current and future use of JAK inhibitors for ET, PV, and MF
How can we predict and reduce the risk of thrombosis in a patient with PV?
Recent advances in the diagnosis, prognosis and survival predictions of patients with PV
Case 2: NCCN Guidelines for Treating Polycythemia Vera
Ongoing trials in polycythemia vera: Low-PV & VERIFY
Risk Stratification and Treatment: Polycythemia Vera
How would you manage a young man with polycythemia vera and fatigue?
Importance of Hematocrit Control in Polycythemia Vera
The current treatment algorithm for polycythemia vera
Комментарии